However, it is known that triple-negative breast cancer is primarily associated with mutations in the TP53 gene, which does not allow us to speak, within the framework of this study, as the only or key mechanism affecting the biology of tumor cells and NIS expression, in particular. Here, SLC5A5 is linked to triple-negative breast carcinoma.